2 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Withdrawn 2 |
Follow Hyperlipidemia: new trials by email Literature Review of Hyperlipidemia trials Research Report on Hyperlipidemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dyslipidemia NK-104-CR, Livalo® IR, Placebo (for NK-104-CR) - Hyperlipidemia, Dyslipidemia | Phase 3 | Withdrawn | Kowa Research Institute, Inc. | 2016-02-01 | 2021-05-10 | |
| Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia NK-104-CR, Placebo, Livalo - Hyperlipidemia, Dyslipidemia | Phase 3 | Withdrawn | Kowa Research Institute, Inc. | 2016-01-01 | 2021-05-10 |
Dyslipidemias (2) · Hyperlipidemias (2)
Lipid Metabolism Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2)
pitavastatin (1)
Kowa Research Institute, Inc. (2)
United States (2)